Inaktiver Wert

Andere Sprachen RLS Global AB (publ)

Aktien

RLS Global to Submit Bankruptcy Application	20.11.
RLS Global ansöker om konkurs	20.11.
RLS Global Abandons ChloraSolv Partnership with ConvaTec Group	10.11.
RLS Global Launches Strategic Review of Options for ChloraSolv Commercialization	10.11.
RLS Global initiates strategic review process aiming to commercialize ChloraSolv	09.11.
RLS Global Initiates Strategic Review Process Aiming to Commercialize ChloraSolv	09.11.
RLS Global and Convatec have agreed to terminate collaboration agreement	09.11.
RLS Global and Convatec Agree to Terminate Collaboration Agreement	09.11.
RLS Global Enrols First Patient in Clinical Trial on Pressure Ulcers	06.09.23
First patient included in new clinical investigation on pressure ulcers	06.09.23
RLS Global AB Announces First Patient Included in New Clinical Investigation on Pressure Ulcers	06.09.23
ChloraSolv recommended for UK CA certification required for UK market after Brexit	01.09.23
RLS Global Q2 2023 - Uncertain future	28.08.23
RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023	25.08.23
RLS Global AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25.08.23
RLS Global Receives SEK5 Million Loan	25.08.23
RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0	24.08.23
RLS Global Names New CFO	22.08.23
RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer	22.08.23
RLS Global AB Announces Chief Financial Officer Changes	22.08.23

Keine Ergebnisse zu dieser Suche